Revenue

Hexagon Purus erases a $12.9M debt in its Panasonic battery deal but gives up lucrative US tax credits, a move securing its supply chain at a high cost.

A Chinese biotech is pioneering next-gen cancer drugs that promise higher precision and fewer side effects. Is this the future of oncology treatment?

Denali Therapeutics raises $200M to advance its brain-penetrating drugs, betting big on its pipeline despite short-term market jitters.

Following stellar clinical data, Terns Pharmaceuticals' upsized $650M offering signals massive investor confidence and funds its push to disrupt the CML market.

A new $300M blank check company is hunting for the foundational tech of the decentralized web. Is this the smart money's bet on crypto's next boom?

Beijing 101 blends TCM with high-tech devices for scalp care. We analyze the business strategy behind this fusion in a competitive wellness market.

A 1.01 Tbps cyberattack was just a skirmish in a wider war. See how advanced AI and massive defenses are the new front line against digital extortion.

The junior explorer is terminating its NWA project option to double down on promising uranium anomalies in Wyoming and a major conductive corridor in Athabasca.

WSFS Bank's parent company executes a savvy refinancing move, signaling strength and confidence in the regional banking sector amid shifting markets.

Gossamer Bio's recent 200,000-share grant to a new hire is more than a welcome bonus; it's a strategic bet on its blockbuster drug candidate.

BNY Mellon's steady dividend offers a window into the high-yield debt market, a crucial, high-risk funding source for the mining sector's energy transition.

CEO Amy Perry’s influence is celebrated, but her true test is securing Banner’s vast, AI-driven ecosystem from the escalating threats of the digital age.

Beyond the gas pump, Casey's is winning with a savvy M&A strategy and a food service empire that rivals fast-food chains. Here’s what it means.

Beyond a simple payout, Qnity Electronics' increased dividend reveals its deep financial strength and strategic position fueling the AI and HPC revolution.

A new neuroscience framework reveals why ethical leaders attract criticism, shifting the focus from leadership flaws to the observer's own brain.

Beyond a simple FDA approval, Amneal's entry into the epinephrine vial market is a calculated move to fix a broken supply chain and drive growth.

Coveo manages a key executive transition by doubling down on its AI-driven growth story, reassuring investors that its innovation engine remains in high gear.

Grant Eason's promotion to Managing Director reveals more than a career move; it's a key to Capital Southwest's strategy in the heated private credit market.

With a new $730K grant, Sunrise New Energy is tackling silicon-carbon anode challenges to unlock the next generation of high-density batteries.

The creator economy has mastered ROI-driven engagement. Can healthcare use its AI-powered playbook to improve patient outcomes and combat misinformation?